<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173230/" ref="ordinalpos=2523&amp;ncbi_uid=3491764&amp;link_uid=PMC3173230" image-link="/pmc/articles/PMC3173230/figure/F6/" class="imagepopup">FIGURE 6. From: Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism. </a></div><br /><div class="p4l_captionBody"><b>Proposed scheme for protective actions of adiponectin on DOX-induced cardiomyopathy.</b> Adiponectin activates SphK-1/Akt signaling via an LRP1/CRT-dependent pathway, and this pathway protects against DOX-induced cardiac dysfunction by its ability to attenuate myocardial apoptosis.</div></div>